DAX24.472 -0,9%Est505.989 -1,1%MSCI World4.343 -0,1%Top 10 Crypto9,7100 -1,9%Nas24.375 -0,4%Bitcoin63.923 +1,5%Euro1,1774 +0,4%Öl94,27 +2,0%Gold4.817 -0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 SAP 716460 Lufthansa 823212 NVIDIA 918422 Siemens Energy ENER6Y NEL ASA A0B733 Infineon 623100 Deutsche Telekom 555750 Mercedes-Benz Group (ex Daimler) 710000 ITM Power A0B57L Microsoft 870747 Commerzbank CBK100 Deutsche Bank 514000 Allianz 840400 Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nahost-Konflikt im Blick: DAX in Rot -- Wall Street stabil -- Alphabet verhandelt mit Marvell über KI-Chips -- NEL, ITM Power, BYD, DroneShield, Siemens Energy, VW, Lufthansa & Co. im Fokus
Top News
Bernstein Research bescheinigt Market-Perform für RWE-Aktie Bernstein Research bescheinigt Market-Perform für RWE-Aktie
NASDAQ Composite Index-Wert Intel-Aktie: So viel hätte eine Investition in Intel von vor einem Jahr abgeworfen NASDAQ Composite Index-Wert Intel-Aktie: So viel hätte eine Investition in Intel von vor einem Jahr abgeworfen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Zealand Pharma A-S Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
42,65 EUR -0,80 EUR -1,84 %
STU
42,53 EUR -1,08 EUR -2,48 %
GVIE
finanzen.net zero
Zealand Pharma A-S jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.3,11 Mrd. EUR

KGV5,09Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA0YJW7

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINDK0060257814

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolZLDPF

Zealand Pharma A-S Aktien News

DatumMeistgelesen
GlobeNewswireZealand Pharma increases its share capital as a result of the exercise of employee warrants
GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswireZealand Pharma announces closing of collaboration and license agreement with Roche
Wer­bungZealand Pharma A-S-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
GlobeNewswireZealand Pharma Announces Financial Results for the First Three Months of 2025
GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswireZealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025
GlobeNewswireTotal number of shares and voting rights in Zealand Pharma as of March 31, 2025
GlobeNewswireResolutions from Zealand Pharma's Annual General Meeting 2025
GlobeNewswireZealand Pharma major shareholder announcement: Van Herk Investments B.V.
GlobeNewswireZealand Pharma increases its share capital as a result of the exercise of employee warrants
GlobeNewswireZealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
GlobeNewswireZealand Pharma convenes its Annual General Meeting 2025
GlobeNewswireZealand Pharma Announces Financial Results for the Full Year 2024
GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswireZealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
GlobeNewswireU.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome
GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswireZealand Pharma Announces Financial Results for the First Nine Months of 2024
GlobeNewswireZealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
GlobeNewswireZealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide
GlobeNewswireTotal number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
GlobeNewswireZealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswireTotal number of shares and voting rights in Zealand Pharma on August 30, 2024
GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
GlobeNewswireZealand Pharma major shareholder announcement: Bank of America Corporation
GlobeNewswireZealand Pharma Announces Financial Results for the First Half of 2024
GlobeNewswireZealand Pharma major shareholder announcement: Van Herk Investments
GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at June 28, 2024
GlobeNewswireZealand Pharma completes registration of capital increase
GlobeNewswireZealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion
GlobeNewswireZealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
GlobeNewswireZealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
GlobeNewswireZealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide
GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
GlobeNewswireZealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
GlobeNewswireZealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL
GlobeNewswireZealand Pharma major shareholder announcement: Polar Capital

Zealand Pharma A-S News

Zealand Pharma A-S News: auf dieser Seite finden Sie alle Zealand Pharma A-S News und Nachrichten zur Zealand Pharma A-S Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Zealand Pharma A-S News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Zealand Pharma A-S News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.